A phase II clinical trial of sorafenib in androgen-independent prostate cancer by Dahut William L, Scripture Charity, Posadas Edwin, Jain Lokesh, Gulley James L, Arlen Philip M, Wright John J, Yu Yunkai, Cao Liang, Steinberg Seth M, Aragon-Ching Jeanny B, Venitz J├╝rgen, Jones Elizabeth, Chen Clara C, Figg William D in Clinical cancer research : an official journal of the American Association for Cancer Research (2008).

[PMID: 18172272] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.